그린 케미스트리 시장 : 그린 케미스트리에 대한 노력, 그린 케미스트리 및 솔루션 제공업체들의 경쟁 상황, 새로운 메가트렌드, 주요 제약사의 노력, 기업 프로파일, 주요 촉진요인 및 억제요인

Green Chemistry Market: Focus on Green Chemistry Initiatives, Competitive Landscape of Green Chemistry Solution Providers, Emerging Mega Trends, Big Pharma Initiatives, Company Profiles and Key Drivers and Restraints

US $ 4,799 ￦ 6,943,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 10,126,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 15,335,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 26,042,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

제약회사가 연구 및 제조 공정에서 그린 케미스트리를 채택한 사용 사례는 60여 개가 넘는 것으로 알려져 있으며, 그린 케미스트리 시장은 꾸준한 속도로 발전할 것으로 예상됩니다.

그린 케미스트리는 유해 물질을 최소화하거나 제거하는 화학제품 및 공정의 설계, 개발 및 도입을 포함합니다. 제약 산업에서 그린 케미스트리는 환경 지속가능성을 촉진하고 화학 합성의 효율성을 향상시키는 데 필수적입니다. 전통적인 의약품 제조는 에너지 집약적이고 재생 불가능한 자원에 의존하기 때문에 많은 양의 폐기물을 발생시키고 처리 비용이 많이 듭니다. 예를 들어, 전 세계 의약품 유효성분(API) 생산량은 연간 6,500만-1억 킬로그램으로 추정되며, 약 100억 킬로그램의 폐기물이 발생하며, 그 처리 비용은 약 200억 달러에 달합니다.

제약 산업은 전 세계 이산화탄소 배출량의 약 17%를 차지하고 있으며, 그 중 절반 가까이가 원료의약품과 그 원료의 제조에 기인합니다. 환경에 대한 관심이 높아짐에 따라 보다 친환경적인 제조 방식을 채택하는 것이 시급한 과제가 되었습니다. 이에 따라 제약사들은 광화학, 전기화학, 생촉매 등 다양한 기술을 활용하여 그린 케미스트리의 원리를 업무에 적용하고 있습니다. 제약 업계에서 생촉매는 화학합성에서 그린 케미스트리의 중요한 적용 사례로 꼽힙니다. 이 접근법은 생산 시간 80% 단축, 생산 수율 향상, 원료 비용의 99% 이상 절감, 정제 공정에서 유기 용매의 사용 중단 등 큰 이점을 입증했습니다.

그린 케미스트리는 유해 물질에 대한 의존도 감소, 비용 절감, 공정 효율성 향상 등 제약 업계에 다양한 이점을 제공합니다. 따라서 많은 제약회사들이 지속가능한 미래를 보장하기 위해 그린 케미스트리에 점점 더 많은 노력을 기울이고 있습니다. 특히 AstraZeneca, BASF, Pfizer와 같은 기업들은 2040년 또는 2050년까지 전체 공급망에서 순 배출량을 제로로 만드는 것을 목표로 하고 있습니다. 이러한 노력은 세계 규제 기준에 부합하고, 친환경 제품에 대한 소비자의 수요 증가에 부응하기 위한 것입니다.

기업들이 그린 케미스트리와 지속가능한 기술에 대한 투자를 늘리면서 그린 케미스트리 시장은 크게 성장할 것으로 예상되며, 의약품 개발 및 제조에서 보다 지속가능하고 책임감 있는 미래로 나아갈 수 있는 길을 열어줄 것으로 기대됩니다.

이 보고서는 세계 그린 케미스트리 시장을 조사했으며, 시장 개요와 함께 그린 케미스트리 솔루션 제공업체들의 경쟁 상황, 새로운 메가트렌드, 주요 제약사의 노력, 기업 프로파일 등을 조사하여 전해드립니다.

목차

섹션 I : 보고서 개요

제1장 범위와 목적

제2장 조사 방법

섹션 II : 정성적인 인사이트

제3장 주요 요약

제4장 소개

섹션 III : 시장 개요

제5장 시장 상황 : 제약 업계의 그린 케미스트리의 대처

제6장 시장 상황 : 그린 케미스트리 솔루션 프로바이더

섹션 IV : 기업 개요로 사례 연구

제7장 기업 개요

• 분석 개요
• Amgen
• AstraZeneca
• Bristol Myers Squibb
• Codexis
• Johnson & Johnson
• Merck
• Merck KGaA
• Pfizer

제8장 사례 연구 : 대형 제약회사의 대처

제5장 시장 동향

제9장 그린 케미스트리 시장 : 진행중인 메가트렌드 개요

제10장 시장에 대한 영향 분석 : 촉진요인, 억제요인, 기회, 과제

제5장 부록

제11장 표형식 데이터

제12장 기업·단체 리스트

ksm

영문 목차

영문목차

With more than 60 known use cases in which pharmaceutical companies have employed green chemistry in their research / manufacturing processes, the green chemistry market is anticipated to evolve at a steady pace.

Green chemistry involves the design, development and implementation of chemical products and processes that minimize or eliminate hazardous substances. In the pharmaceutical industry, green chemistry is vital for promoting environmental sustainability and improving the efficiency of chemical synthesis. Traditional drug manufacturing is energy-intensive and dependent on non-renewable resources, leading to significant waste generation and costly disposal. For example, global production of active pharmaceutical ingredients (APIs) is estimated to be 65 million to 100 million kilograms annually, generating approximately 10 billion kilograms of waste, with disposal costs around $20 billion.

The pharmaceutical industry is responsible for approximately 17% of global carbon emissions, with nearly half of this footprint stemming from the manufacturing of APIs and their raw materials. With increasing environmental concerns, there is an urgent need for industry to adopt greener production methods. Consequently, pharmaceutical companies are integrating green chemistry principles into their operations, utilizing various techniques such as photochemistry, electrochemistry, and biocatalysis. In the pharmaceutical industry, biocatalysis presents a significant application of green chemistry in chemical synthesis. This approach has demonstrated significant advantages, including reduction in manufacturing time by 80%, increase in production yield, decrease in the cost of starting materials by more than 99%, and elimination of the use of organic solvents during purification processes.

Green chemistry provides various benefits to the pharmaceutical industry, including reduced reliance on toxic substances, cost savings, and enhanced process efficiency. Thus, many pharmaceutical companies are increasingly focusing on green chemistry to ensure a sustainable future. Notably, firms such as AstraZeneca, BASF, and Pfizer are aiming for net-zero emissions across their supply chains by 2040 or 2050. These efforts align with global regulatory standards and respond to rising consumer demand for eco-friendly products.

As companies increasingly invest in green chemistry and sustainable technologies, the green chemistry market is expected to experience substantial growth, paving the way for a more sustainable and responsible future in drug development and manufacturing.

Research Coverage:

The report on green chemistry market covers the following elements:

• A project background providing an introduction to the context of the green chemistry market report and outlining various project objectives.
• An overview of the systematic research methodology employed to study the green chemistry industry, providing information on various assumptions, methodologies, and quality control measures used to ensure the accuracy and reliability of our findings.
• An infographic executive summary presenting key insights gathered during our research, providing a high-level perspective on the current state of green chemistry initiatives and green chemistry solution providers.
• A general overview of green chemistry, covering the 12 principles of green chemistry and prominent types of green chemistry methods. It also discusses various applications of green chemistry and addresses the challenges associated with its implementation.
• A comprehensive assessment of green chemistry initiatives within the pharma industry, based on several relevant parameters, such as the type of green chemistry method involved (biocatalysis, electrochemistry, photochemistry and others), purpose of initiative (research and manufacturing), therapeutic area of drug synthesized (cardiovascular disorders, infectious diseases, metabolic disorders, neurological disorders, oncological disorders, respiratory disorders and other disorders) and impact of initiative (energy efficient processes, improvement in yield, reduction in carbon footprint, reduction in manufacturing time, reduction in metal consumption, reduction in solvent-use, reduction in waste and others). Further, the report also provides information on the green chemistry initiatives stakeholders, along with analysis on various parameters, such as year of establishment, company size (in terms of employee count) and location of headquarters (region and country).
• An evaluation of the green chemistry solution providers, based on various relevant parameters, such as year of establishment, company size (in terms of employee count) and location of headquarters (region and country), type of solution offered (product, platform and service), type of green chemistry method involved (biocatalysis, electrochemistry and photochemistry), pharmaceutical application (research, manufacturing and other applications), and type of service offered (research, product / process development, manufacturing, scale-up and other services).
• Elaborate profiles of key companies in the green chemistry market. Each profile includes a brief overview of the company (year of establishment, location of headquarters, number of employees, management team and business segments), information on their green chemistry initiatives, recent developments and an informed future outlook.
• A comprehensive case study on big pharma initiatives that examine the impact of green chemistry practices on the pharmaceutical industry.
• A detailed assessment of various ongoing megatrends in the green chemistry industry, including rising demand for sustainable drug manufacturing, technological advancements in green chemistry practices, integration of continuous flow manufacturing with green chemistry practices, convergence of AI, data science with green chemistry applications, development of sustainability metrices, and many more.
• A detailed analysis identifying factors that influence the growth of green chemistry market. It includes insights into key drivers, potential restraints, emerging opportunities, and existing challenges in this domain.

Key Benefits of Buying this Report

• The report provides valuable insights into key green chemistry solution providers that are shaping the market landscape and driving sustainable practices in the industry.
• Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
• The report provides stakeholders with an overall outlook of the green chemistry market, featuring essential information on significant market drivers, barriers, opportunities, and challenges.

Example Companies Profiled

• Amgen
• AstraZeneca
• Bristol Myers Squibb
• Codexis
• Johnson & Johnson
• Merck
• Merck KGaA
• Pfizer

TABLE OF CONTENTS

SECTION I: REPORT OVERVIEW

1. SCOPE AND OBJECTIVES

• 1.1. Context
• 1.2. Project Objectives

2. RESEARCH METHODOLOGY

• 2.1. Project Methodology
• 2.2. Robust Quality Control Framework

SECTION II: QUALITATIVE INSIGHTS

3. EXECUTIVE SUMMARY

4. INTRODUCTION

• 4.1. An Overview of Green Chemistry
• 4.2. 12 Principles of Green Chemistry
• 4.3. Types of Green Chemistry Methods
• 4.4. Applications of Green Chemistry
• 4.5. Key Challenges in Green Chemistry Domain

SECTION III: MARKET OVERVIEW

5. MARKET LANDSCAPE: GREEN CHEMISTRY INITIATIVES IN PHARMA INDUSTRY

• 5.1. Methodology and Key Parameters
• 5.2. Green Chemistry Initiatives: Overall Market Landscape
  • 5.2.1. Analysis by Type of Green Chemistry Method Involved
  • 5.2.2. Analysis by Purpose of Initiative
  • 5.2.3. Analysis by Therapeutic Area of Drug Synthesized
  • 5.2.4. Analysis by Impact of Initiative
• 5.3. Green Chemistry Initiatives Stakeholders: Overall Market Landscape
  • 5.3.1. Analysis by Year of Establishment
  • 5.3.2. Analysis by Company Size
  • 5.3.3. Analysis by Location of Headquarters

6. MARKET LANDSCAPE: GREEN CHEMISTRY SOLUTION PROVIDERS

• 6.1. Methodology and Key Parameters
• 6.2. Green Chemistry Solution Providers: Overall Market Landscape
  • 6.2.1. Analysis by Year of Establishment
  • 6.2.2. Analysis by Company Size
  • 6.2.3. Analysis by Location of Headquarters
  • 6.2.4. Analysis by Type of Solution Offered
  • 6.2.5. Analysis by Type of Green Chemistry Method Involved
  • 6.2.6. Analysis by Pharmaceutical Application
  • 6.2.7. Analysis by Type of Service Offered

SECTION IV: COMPANY PROFILES AND CASE STUDY

7. COMPANY PROFILES

• 7.1. Chapter Overview
• 7.2. Amgen
  • 7.2.1. Company Overview
  • 7.2.2. Company Mission
  • 7.2.3. Company Footprint
  • 7.2.4. Management Team
  • 7.2.5. Contact Details
  • 7.2.6. Green Chemistry Initiatives
  • 7.2.7. Recent Developments and Future Outlook
• 7.3. AstraZeneca
  • 7.3.1. Company Overview
  • 7.3.2. Company Mission
  • 7.3.3. Company Footprint
  • 7.3.4. Management Team
  • 7.3.5. Contact Details
  • 7.3.6. Green Chemistry Initiatives
  • 7.3.7. Recent Developments and Future Outlook
• 7.4. Bristol Myers Squibb
  • 7.4.1. Company Overview
  • 7.4.2. Company Mission
  • 7.4.3. Company Footprint
  • 7.4.4. Management Team
  • 7.4.5. Contact Details
  • 7.4.6. Green Chemistry Initiatives
  • 7.4.7. Recent Developments and Future Outlook
• 7.5. Codexis
  • 7.5.1. Company Overview
  • 7.5.2. Company Mission
  • 7.5.3. Company Footprint
  • 7.5.4. Management Team
  • 7.5.5. Contact Details
  • 7.5.6. Green Chemistry Initiatives
  • 7.5.7. Recent Developments and Future Outlook
• 7.6. Johnson & Johnson
  • 7.6.1. Company Overview
  • 7.6.2. Company Mission
  • 7.6.3. Company Footprint
  • 7.6.4. Management Team
  • 7.6.5. Contact Details
  • 7.6.6. Green Chemistry Initiatives
• 7.7. Merck
  • 7.7.1. Company Overview
  • 7.7.2. Company Mission
  • 7.7.3. Company Footprint
  • 7.7.4. Management Team
  • 7.7.5. Contact Details
  • 7.7.6. Green Chemistry Initiatives
  • 7.7.7. Recent Developments and Future Outlook
• 7.8. Merck KGaA
  • 7.8.1. Company Overview
  • 7.8.2. Company Mission
  • 7.8.3. Company Footprint
  • 7.8.4. Management Team
  • 7.8.5. Contact Details
  • 7.8.6. Green Chemistry Initiatives
  • 7.8.7. Recent Developments and Future Outlook
• 7.9. Pfizer
  • 7.9.1. Company Overview
  • 7.9.2. Company Mission
  • 7.9.3. Company Footprint
  • 7.9.4. Management Team
  • 7.9.5. Contact Details
  • 7.9.6. Green Chemistry Initiatives
  • 7.9.7. Recent Developments and Future Outlook

8. CASE STUDY: BIG PHARMA INITIATIVES

• 8.1. Methodology and Key Parameters
• 8.2. Green Chemistry: Big Pharma Initiatives
  • 8.2.1. Johnson & Johnson
  • 8.2.2. Roche
  • 8.2.3. Merck
  • 8.2.4. Pfizer
  • 8.2.5. AbbVie
  • 8.2.6. AstraZeneca
  • 8.2.7. Novartis
  • 8.2.8. Bristol Myers Squibb
  • 8.2.9. GlaxoSmithKline

SECTION V: MARKET TRENDS

9. GREEN CHEMISTRY MARKET: OVERVIEW OF ONGOING MEGA TRENDS

• 9.1. Megatrends in the Green Chemistry Market
  • 9.1.1. Shift Towards Sustainable Drug Manufacturing
  • 9.1.2. Technological Advancements in Green Chemistry
  • 9.1.3. Integration of Continuous Flow Manufacturing in Green Chemistry
  • 9.1.4. Emphasis on Waste Valorization and Circular Chemistry
  • 9.1.5. Convergence of AI, Data Science and Green Chemistry
  • 9.1.6. Establishing Sustainability Metrices
  • 9.1.7. Increasing Adoption by Big-Pharma Companies
  • 9.1.8. Growing Regulatory Pressures

10. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

• 10.1. Market Drivers
• 10.2. Market Restraints
• 10.3. Market Opportunities
• 10.4. Market Challenges

SECTION V: APPENDIX

11. TABULATED DATA

12. LIST OF COMPANIES AND ORGANIZATIONS

관련자료